Mikael Eriksson

31.5k total citations · 1 hit paper
305 papers, 8.8k citations indexed

About

Mikael Eriksson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mikael Eriksson has authored 305 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 83 papers in Pulmonary and Respiratory Medicine and 56 papers in Cancer Research. Recurrent topics in Mikael Eriksson's work include Global Cancer Incidence and Screening (46 papers), Digital Radiography and Breast Imaging (35 papers) and Breast Cancer Treatment Studies (29 papers). Mikael Eriksson is often cited by papers focused on Global Cancer Incidence and Screening (46 papers), Digital Radiography and Breast Imaging (35 papers) and Breast Cancer Treatment Studies (29 papers). Mikael Eriksson collaborates with scholars based in Sweden, United States and United Kingdom. Mikael Eriksson's co-authors include Lennart Hardell, Per Hall, Kamila Czene, Charles L. Sentman, Charles R. Wira, Michael Carlberg, Sarah K. Meadows, Erik Lundgren, Per Lenner and Jingmei Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Mikael Eriksson

293 papers receiving 8.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma?

2009 568 citations Mikael Eriksson et al. International Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mikael Eriksson Sweden	49	2.1k	2.1k	1.6k	1.0k	1.0k	305	8.8k
John J. Spinelli Canada	49	2.5k 1.2×	1.7k 0.8×	2.7k 1.7×	1.3k 1.3×	601 0.6×	218	9.7k
Richard K. Severson United States	56	2.6k 1.2×	1.8k 0.9×	1.5k 0.9×	1.7k 1.7×	650 0.6×	189	9.7k
Elizabeth T. H. Fontham United States	48	4.1k 2.0×	3.0k 1.4×	1.2k 0.7×	1.1k 1.1×	679 0.7×	155	10.4k
Wendy Cozen United States	52	3.1k 1.5×	1.2k 0.6×	1.4k 0.8×	2.3k 2.2×	1.1k 1.0×	208	10.7k
Lutz Edler Germany	52	2.1k 1.0×	1.6k 0.8×	1.3k 0.8×	414 0.4×	834 0.8×	245	8.6k
Rachel Ε. Neale Australia	46	4.0k 1.9×	1.0k 0.5×	942 0.6×	1.5k 1.5×	578 0.6×	266	10.0k
Bernard F. Cole United States	54	3.6k 1.7×	3.6k 1.7×	1.3k 0.8×	1.1k 1.1×	537 0.5×	179	9.3k
Faith G. Davis United States	47	2.5k 1.2×	2.9k 1.4×	1.4k 0.9×	580 0.6×	492 0.5×	147	10.4k
Robert Dubrow United States	56	2.3k 1.1×	1.9k 0.9×	969 0.6×	648 0.6×	290 0.3×	169	11.2k
Julian Little Canada	61	3.0k 1.4×	1.4k 0.7×	1.1k 0.7×	886 0.9×	585 0.6×	365	16.2k

Countries citing papers authored by Mikael Eriksson

Since Specialization

Citations

This map shows the geographic impact of Mikael Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Eriksson more than expected).

Fields of papers citing papers by Mikael Eriksson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Eriksson. The network helps show where Mikael Eriksson may publish in the future.

Co-authorship network of co-authors of Mikael Eriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Eriksson. A scholar is included among the top collaborators of Mikael Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Eriksson. Mikael Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Xin, Yon Ho Jee, Yu Cao, et al.. (2025). Evaluating mammographic density′s contribution to improve a breast cancer risk model with questionnaire-based and polygenic factors. npj Breast Cancer. 11(1). 106–106.

Yip, Desmond, John Zalcberg, Jean‐Yves Blay, et al.. (2025). Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial. British Journal of Cancer. 132(10). 897–904. 1 indexed citations

Mansten, Erik, et al.. (2024). Cancellation of klystron-induced energy and arrival-time variations in linear accelerators with arc-type bunch compressors. Physical Review Accelerators and Beams. 27(4). 2 indexed citations

Mariapun, Shivaani, Weang-Kee Ho, Mikael Eriksson, et al.. (2023). Evaluation of SNPs associated with mammographic density in European women with mammographic density in Asian women from South-East Asia. Breast Cancer Research and Treatment. 201(2). 237–245. 1 indexed citations

Graßmann, Felix, Anders Mälarstig, Matilda Dale, et al.. (2023). The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk. British Journal of Cancer. 130(4). 620–627. 4 indexed citations

Eriksson, Mikael, Marta Román, Axel Gräwingholt, et al.. (2023). European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening—a nested case-control study. The Lancet Regional Health - Europe. 37. 100798–100798. 10 indexed citations

Hurson, Amber N., Parichoy Pal Choudhury, Chi Gao, et al.. (2021). Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries. International Journal of Epidemiology. 50(6). 1897–1911. 43 indexed citations

Graßmann, Felix, Keith Humphreys, Jingmei Li, et al.. (2020). Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns. International Journal of Cancer. 148(4). 884–894. 3 indexed citations

Eriksson, Mikael, Ralf Kuja‐Halkola, Shadi Azam, et al.. (2020). Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses. Cancer Research. 80(7). 1590–1600. 24 indexed citations

10.

He, Wei, Felix Graßmann, Mikael Eriksson, et al.. (2019). CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer. Journal of Clinical Oncology. 38(6). 548–557. 34 indexed citations

11.

Li, Jingmei, Wei Wen, Brennan Decker, et al.. (2018). Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer. Cancer Research. 78(21). 6329–6338. 16 indexed citations

12.

Strand, Fredrik, Keith Humphreys, Johanna Holm, et al.. (2018). Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening. Breast Cancer Research. 20(1). 31–31. 10 indexed citations

13.

Holm, Johanna, Louise Eriksson, Alexander Ploner, et al.. (2017). Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity. Cancer Research. 77(13). 3708–3717. 84 indexed citations

14.

Joensuu, Heikki, Mikael Eriksson, Kirsten Sundby Hall, et al.. (2015). Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial. Journal of Clinical Oncology. 34(3). 244–250. 149 indexed citations

15.

Pulczynski, Elisa Jacobsen, Outi Kuittinen, Martin Erlanson, et al.. (2014). Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group. Haematologica. 100(4). 534–540. 79 indexed citations

16.

Fransson, Martin N., et al.. (2012). A Minimum Data Set for Sharing Biobank Samples, Information, and Data: MIABIS. Biopreservation and Biobanking. 10(4). 343–348. 73 indexed citations

17.

Angal-Kalinin, D., et al.. (2010). Bunch Compression by Linearising Achromats for the MAX IV Injector. Lund University Publications (Lund University). 2 indexed citations

18.

Ladfors, Lars, L. Mattsson, Mikael Eriksson, & Ian Milsom. (2000). Prevalence and risk factors for prelabor rupture of the membranes (PROM) at or near term in an urban Swedish population. Journal of Perinatal Medicine. 28(6). 491–6. 25 indexed citations

19.

Eriksson, Mikael, et al.. (1996). Complicated Course of Local Mycobacterial Infection in an Immunocompetent Girl. Scandinavian Journal of Infectious Diseases. 28(1). 99–100. 3 indexed citations

20.

Eriksson, Mikael, Lennart Hardell, & Hans‐Olov Adami. (1990). Exposure to Dioxins as a Risk Factor for Soft Tissue Sarcoma: A Population - Based Case-Control Study. JNCI Journal of the National Cancer Institute. 82(6). 486–490. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact